MOH — authorised 23 December 1980
- Marketing authorisation holder: ROXANE
- Status: likely_approved
MOH authorised Lithium Citrate on 23 December 1980
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 23 December 1980.
ROXANE holds the Israeli marketing authorisation.